STOCK TITAN

Oxford Square Capital 5.50% Notes due 2028 (OXSQG) Form 4 Filings

OXSQG NASDAQ

Here are the Form 4 insider transactions from Oxford Square Capital Corp. 5.50% Notes due 2028 (OXSQG) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow OXSQG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full OXSQG filings page.

Rhea-AI Summary

Oxford Square Capital Corp. (OXSQ) CEO Jonathan H. Cohen reported two common-stock purchases for a joint tenants in common account. The reported amounts reflect Cohen's 50% pecuniary interest; issuer President and COO Saul B. Rosenthal also has a 50% pecuniary interest. Cohen's reported purchases were 21,678 shares at a $0.55 weighted average price on November 19, 2026 and 23,266 shares at a $0.5448 weighted average price on November 18, 2026. Neither purchase was reported as made under a Rule 10b5-1 plan. A separate holding entry lists 2,169 shares held by Oxford Funds, LLC, which may be deemed beneficially owned by Cohen through his ownership interest.

Rhea-AI Summary

Oxford Square Capital Corp. President and COO Saul B. Rosenthal reported purchases totaling 44,943 shares on November 18 and 19, 2026, at weighted average prices of $0.5448 and $0.55, respectively. The reported shares represent only Rosenthal’s 50% pecuniary interest in a joint tenants in common account; Jonathan H. Cohen, the company’s CEO and a director, also has a 50% pecuniary interest. No Rule 10b5-1 plan is reported. A separate indirect holding entry lists 2,169.448 shares held by Oxford Funds, LLC, which may be deemed beneficially owned by Rosenthal through his ownership interest.

Rhea-AI Summary

Oxford Square Capital Corp. (OXSQ) director Steven P. Novak reported selling 5,000 shares of common stock on September 3, 2026 in an open-market or private transaction at $1.355 per share. The sold shares were held indirectly in his capacity as executor of his spouse’s estate. After this sale, he reports 15,000.7586 shares held indirectly as executor and 10,000 shares held directly. No transactions in this filing are reported as made under a Rule 10b5-1 trading plan.

Rhea-AI Summary

Oxford Square Capital Corp. President and COO Saul B. Rosenthal bought shares of the company in the open market. On May 20, 2026, he purchased 144,703 shares of common stock at a weighted average price of $1.1517 per share in an open-market transaction.

The purchased shares were acquired into a joint tenants in common account in which Rosenthal has a 50% pecuniary interest, with CEO Jonathan H. Cohen holding the other 50%. After this transaction, Rosenthal directly owned 2,201,479 common shares and indirectly held 1,898 shares through Oxford Funds, LLC, which may be deemed beneficially owned by him.

Rhea-AI Summary

Oxford Square Capital Corp. Chief Executive Officer Jonathan H. Cohen reported an open-market purchase of 144,704 shares of common stock at a weighted average price of $1.1517 per share on May 20, 2026. The shares were bought into a joint tenants in common account in which Cohen has a 50% pecuniary interest and President and COO Saul B. Rosenthal holds the other 50%. Following this transaction, Cohen directly owns 2,417,193 common shares and indirectly holds 1,898 additional shares through Oxford Funds, LLC, which may be deemed beneficially owned by him.